Clinical Trials Browser

Cholangiocarcinoma × Combined Modality Therapy × Gastrointestinal × Clear all

NCT04413734 2020-06-04

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma